Here’s what you need to know.
1. The company traded at $21.05 on Friday. It opened the day at $21.73.
2. Director Brian E. Farley sold 30,000 of the firm’s shares for a total of $667,800.
3. Mr. Farley owns 514,581 shares of the company at a value of $11.4 million.
4. Despite that four research analysts still gave the firm a buy rating. Zacks Investment recently downgraded Entellus from a buy rating to a hold rating.
More spine/ortho news:
25 Mazor systems purchased in Q3, Medtronic accounts for 15
St. Jude Medical receives FDA approval, announces 1st implant of Infinity DBS system: 5 observations
Medicrea’s 2016 Q3 sales hit €6.8M — 6 report highlights
